Congress Asset Management Co. Sells 219,394 Shares of The Cooper Companies, Inc. $COO

Congress Asset Management Co. cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 48.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 232,899 shares of the medical device company’s stock after selling 219,394 shares during the quarter. Congress Asset Management Co. owned 0.12% of Cooper Companies worth $19,088,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Mesirow Financial Investment Management Inc. raised its holdings in Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after acquiring an additional 175 shares in the last quarter. Pacer Advisors Inc. grew its holdings in shares of Cooper Companies by 0.8% during the 3rd quarter. Pacer Advisors Inc. now owns 23,079 shares of the medical device company’s stock worth $1,582,000 after purchasing an additional 182 shares in the last quarter. Citizens Financial Group Inc. RI grew its holdings in shares of Cooper Companies by 2.7% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 7,181 shares of the medical device company’s stock worth $492,000 after purchasing an additional 192 shares in the last quarter. Bell Investment Advisors Inc increased its position in shares of Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares during the period. Finally, Close Asset Management Ltd increased its position in shares of Cooper Companies by 7.2% during the third quarter. Close Asset Management Ltd now owns 3,319 shares of the medical device company’s stock valued at $227,000 after purchasing an additional 224 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently commented on COO. Mizuho set a $100.00 target price on Cooper Companies and gave the stock an “outperform” rating in a research report on Friday, December 5th. Stifel Nicolaus set a $95.00 price target on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research note on Wednesday, March 4th. Citigroup reduced their price objective on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Friday, March 6th. Finally, Wells Fargo & Company lifted their target price on shares of Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, December 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Price Performance

Cooper Companies stock opened at $70.49 on Wednesday. The business has a 50 day simple moving average of $79.49 and a 200 day simple moving average of $76.16. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a market capitalization of $13.75 billion, a PE ratio of 34.90, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Q1 results and near‑term guidance: Cooper reported an EPS beat ($1.10 vs. $1.03 consensus) and revenue roughly in line with expectations; management set Q2 2026 EPS guidance of $4.58–$4.66, supporting the growth story and underwriting the stock’s near‑term strength. (Background: market cap ~ $13.8B, P/E ~34.9, PEG ~1.8)
• Positive Sentiment: Bullish analyst/press coverage: Zacks published pieces highlighting COO as an attractive growth stock and listing reasons growth investors shouldn’t overlook the company — these positive narratives can attract momentum buyers and help sentiment. 3 Reasons Why Growth Investors Shouldn’t Overlook The Cooper Companies (COO)
• Positive Sentiment: Additional Zacks coverage reiterates COO’s top‑ranked growth characteristics, which can reinforce buy-side interest and analyst attention. The Cooper Companies (COO) is a Top-Ranked Growth Stock: Should You Buy?
• Neutral Sentiment: Short‑interest data appears inconsistent/erroneous: multiple reports show “0 shares” shorted and 0.0 days to cover with NaN changes — this looks like a data glitch and provides no reliable signal on bearish positioning.
• Neutral Sentiment: Unrelated market headlines (crypto, other companies): broader media items — e.g., Tether planning a Big Four audit and press on unrelated companies (Cooper‑Standard, Bass Oil, HC Group) — likely have little direct impact on COO’s fundamentals. Tether says ‘Big Four‘ firm to handle first audit of USDT reserves
• Negative Sentiment: Technical/volume caution: the stock is trading below its 50‑day (~$79.71) and 200‑day (~$76.15) moving averages and today’s volume is below average — these factors suggest the intraday uptick may lack broad conviction and could limit near‑term upside until technicals improve.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.